Omentin – a newly-discovered adipocytokine in insulin resistance pathogenesis;Omentyna – nowo odkryta adipocytokina w patogenezie insulinooporności

Polski Merkuriusz Lekarski

Volumn 39, Issue 229, 2015, Pages 56-60

  Lis, Ilona ^a   Pilarski, L ^a   Bogdański, Paweł ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

adipokines; adipose tissue; insulin resistance; omentin

Indexed keywords

ADIPONECTIN; CYTOKINE; GLUCOSE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; ITLN1 PROTEIN, HUMAN; LECTIN;

ADIPOCYTE; ENERGY METABOLISM; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; PHOSPHORYLATION; PHYSIOLOGY;

ADIPOCYTES; ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; CYTOKINES; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; FEMALE; GLUCOSE; GPI-LINKED PROTEINS; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; LECTINS; OBESITY; PHOSPHORYLATION; POLYCYSTIC OVARY SYNDROME;

EID: 84943375522     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Arkan MC, Hevener AL, Greten FR, et al.: IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med, 2005; 11(2): 191-198.
2. Astrup A, Buemann B, Flint A, et al.: Low fat diets and energy balance: how does the evidence stand in 2002? Proc Nutr Soc, 2002; 61(2): 299-309.
3. Auguet T, Quintero Y, Riesco D, et al.: New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med Genet, 2011; 12: 60.
4. Briana DD, Boutsikou M, Baka S, et al.: Omentin-1 and vaspin are present in the fetus and neonate, and perinatal concentrations are similar in normal and growth-restricted pregnancies. Metabolism, 2011; 60(4): 486-490.
5. Cai DS, Yuan M, Frantz DF, et al.: Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappa B. Nat Med, 2005; 11(2): 183-190.
6. Cai RC, Wei L, Di JZ, et al.: Expression of omentin in adipose tissues in obese and type 2 diabetic patients. Zhonghua Yi Xue Za Zhi, 2009; 89 (6): 381-384.
7. Carolan BJ, Harvey BG, De BP, et al.: Decreased expression of intelectin 1 in the human airway epithelium of smokers compared to nonsmokers. J Immunol, 2008; 181(8): 5760-5767.
8. De Souza Batista CM, Yang RZ, Lee MJ, et al.: Omentin plasma levels and gene expression are decreased in obesity. Diabetes, 2007; 56(6): 1655-1661.
9. Dunaif A: Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev, 1997; 18(6): 774 -800.
10. Elbein SC, Hoffman MD, Teng K, et al.: A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes, 1999; 48(5): 1175-1182.
11. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. New Engl J Med, 1999; 340(6): 448-454.
12. Greulich S, Chen WJ, Maxhera B, et al.: Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies. PLoS One, 2013; 8(3): e59697.
13. Gürsoy G, Kirnap NG, Esbah O, et al.: The relationship between plasma omentin-1 levels and insulin resistance in newly diagnosed type 2 diabetic women. Clin Rev Opinions, 2010; 2(4): 49-54.
14. Hanson RL, Ehm MG, Pettitt DJ, et al.: An autosomal genomic scan for loci linked to type II diabetes mellitus and bodymass index in Pima Indians. Am J Hum Genet, 1998; 63(4): 1130-1138.
15. Haus JM, Solomon TP, Marchetti CM, et al.: Free fatty acid-induced hepatic insulin resistance is attenuated following lifestyle intervention in obese individuals with impaired glucose tolerance. J Clin Endocrinol Metab, 2010; 95(1): 323-327.
16. Hotamisligil GS, Peraldi P, Budavari A, et al.: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science, 1996; 271(5249): 665-668.
17. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor-necrosis-factor-alpha – direct role in obesity-linked insulin resistance. Science, 1993; 259(5091): 87-91.
18. Komiya T, Tanigawa Y, Hirohashi S: Cloning of the novel gene intelectin, which is expressed in intestinal paneth cells in mice. Biochem Biophys Res Commun, 1998; 251(3): 759-762.
19. Kuzmicki M, Telejko B, Szamatowicz J, et al.: High resistin and interleukin-6 levels are associated with gestational diabetes mellitus. Gynecol Endocrinol, 2009; 25(4): 258-263.
20. Lewandowski K, Nadel I, Lewinski A, et al.: Positive correlation between serum omentin and thrombospondin-1 in gestational diabetes despite lack of correlation with insulin resistance indices. Ginekol Pol 2010; 81(12): 907-912.
21. Liu R, Wang X, Bu P: Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome. Diabetes Res Clin Pract, 2011; 93(1): 21-25.
22. Matsuzawa Y.: Adiponectin: a key player in obesity related disorders. Curr Pharm Des, 2010; 16(17): 1896-901.
23. Moreno-Navarrete JM, Catalán V, Ortega F, et al.: Circulating omentin concentration increases after weight loss. Nutr Metab, 2010; 7: 27.
24. Moreno-Navarrete JM, Ortega F, Castro A, et al.: Circulating omentin as a novel biomarker of endothelial dysfunction. Obesity, 2011; 19(8): 1552-1559.
25. Pan HY, Guo L, Li Q: Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract, 2010; 88(1): 29-33.
26. Parillo M, Riccardi G: Diet composition and the risk of Type 2 diabetes: epidemiological and clinical evidence. Br J Nutr, 2004; 92(1): 7-19.
27. Pemberton AD, Knight PA, Gamble J, et al.: Innate BALB/c enteric epithelial responses to Trichinella spiralis: inducible expression of a novel goblet cell lectin, intelectin-2, and its natural deletion in C57BL/ 10 mice. J Immunol, 2004; 173(3): 1894-1901.
28. Rabe K, Lehrke M, Parhofer KG, et. al.: Adipokines and insulin resistance. Mol Med, 2008; 14 (11-12): 741-751.
29. Saltiel AR, Pessin JE: Insulin signaling pathways in time and space. Trends Cell Biol, 2002; 12(2): 65-71.
30. Saucedo R, Zarate A, Basurto L, et al.: Relationship between circulating adipokines and insulin resistance during pregnancy and postpartum in women with gestational diabetes. Arch Med Res, 2011; 42(2): 318-323.
31. Schäffler A, Neumeier M, Herfarth H, et al.: Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta, 2005; 1732(1-3): 96-102.
32. Seremi A, Asghari M, Ghorbani A: Effects of aerobic training on serum omentin-1 and cardiometabolic risk factors in overweight and obese men. J Sports Sci, 2010; 28(9): 993-998.
33. Shaker M, Mashhadani ZI, Mehdi AA: Effect of treatment with metformin on omentin-1, ghrelin and other biochemical, clinical fe-atures in PCOS patients. Oman Med J, 2010; 25(4): 289-293.
34. Shi H, Kokoeva MV, Inouye K, et al.: TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest, 2006; 116(11): 3015-3025. pl
35. Svedberg J, Stromblad G, Wirth A, et al.: Fatty-acids in the portal-vein of the rat regulate hepatic insulin-clearance. J Clin Invest, 1991; 88(6): 2054-2058. ess.com
36. Tan BK, Adya R, Farhatullah S, et al.: Metformin treatment may increase omentin levels in women with polycystic ovary syndro-me. Diabetes, 2010; 59(12): 3023-3031. @medp
37. Tan BK, Adya R, Farhatullah S, et al.: Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes, 2008; 57(4): 801-808. [6] medpres
38. The European Group for the Study of Insulin Resistence (EGIR): Frequency of the WHO metabolic syndrome in European cohorts, and alternative definition of an insulin resistance syndrome. Diabetes Metab. 2002; 28(5): 365-376.
39. Trayhurn P, Wood IS: Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr, 2004; 92(3): 347-355.
40. Tsuji S, Uehori J, Matsumoto M, et al.: Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall. J Biol Chem, 2001; 276(26): 23456-23463.
41. Vionnet N, Hani El-H, Dupont S, et al.: Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum.Genet, 2000; 67(6): 1470-1480.
42. Wang C, Mao X, Wang L, et al.: Adiponectin sensitizes insulin signaling by reducing p70 S6 kinase-mediated serine phosphorylation of IRS-1. J Biol Chem, 2007; 282(11): 7991-7996.
43. White MF: The insulin signalling system and the IRS proteins. Diabetologia, 1997; 40/ suppl.2: 2-17.
44. Wild RA, Painter RD, Coulson PB, et al.: Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab, 1985; 61(5): 946 -951.
45. Wiltshire S, Hattersley AT, Hitman GA, et. al.: A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet, 2001; 69(3): 553-556.
46. Wrackmeyer U, Hansen GH, Seya T: Intelectin: a novel lipid raft-associated protein in the enterocyte brush border. Biochemistry, 2006; 45(30): 9188-9197.
47. Xie H, Xie PL, Wu XP, et al.: Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression. Cardiovasc Res, 2011; 92(2): 296-306.
48. Yan P, Liu D, Long M, et al.: Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes, 2011; 119(4): 257-263.
49. Yang RZ, Lee MJ, Hu H, et al.: Identification of omentin as a novel depotspecific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab, 2006; 290(6): 1253-1261.
50. Yu D.: Omentin activates AMP-activated protein kinase and plays a role in energy metabolism and immune response. PhD dissertation. Molecular Medicine: University of Maryland 2011.